Correlation Between HCW Biologics and Vaxcyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Vaxcyte, you can compare the effects of market volatilities on HCW Biologics and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Vaxcyte.

Diversification Opportunities for HCW Biologics and Vaxcyte

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between HCW and Vaxcyte is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of HCW Biologics i.e., HCW Biologics and Vaxcyte go up and down completely randomly.

Pair Corralation between HCW Biologics and Vaxcyte

Given the investment horizon of 90 days HCW Biologics is expected to generate 24.57 times more return on investment than Vaxcyte. However, HCW Biologics is 24.57 times more volatile than Vaxcyte. It trades about 0.13 of its potential returns per unit of risk. Vaxcyte is currently generating about -0.26 per unit of risk. If you would invest  45.00  in HCW Biologics on August 29, 2024 and sell it today you would earn a total of  5.21  from holding HCW Biologics or generate 11.58% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HCW Biologics  vs.  Vaxcyte

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
Vaxcyte 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Vaxcyte are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Vaxcyte showed solid returns over the last few months and may actually be approaching a breakup point.

HCW Biologics and Vaxcyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and Vaxcyte

The main advantage of trading using opposite HCW Biologics and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.
The idea behind HCW Biologics and Vaxcyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stocks Directory
Find actively traded stocks across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal